PORTLAND, Ore., May 4, 2017 /PRNewswire/ -- Otoharmonics has announced that Dr. Donna Grant has joined their team as Director of Business Development. This hire solidifies Otoharmonics' commitment to understanding and helping hearing healthcare providers grow their business in an ever-changing industry landscape.
"The Director of Business Development is responsible for helping providers expand their business using the Levo System," said Michael Baker, President and CEO of Otoharmonics. "Dr. Grant's combination of business acumen matched with her years of experience in the hearing healthcare community makes her a perfect fit for this position."
In her capacity with Otoharmonics, Dr. Grant is responsible for providing business development support to Levo providers throughout the nation. Prior to her time at Otoharmonics, Dr. Donna Grant served as Program Manager for Sivantos, Inc. She received her Doctorate in Audiology from Towson University and is a Fellow of the American Academy of Audiology and a member of the American Speech Language and Hearing Association.
"I'm very excited about this opportunity to help providers develop their tinnitus programs using the Levo System," added Dr. Donna Grant, Director of Business Development. "This kind of innovation is just what hearing healthcare providers need to stand out in an increasingly competitive landscape."
Utilizing an FDA-cleared evidence-based approach, the Levo System offers a patented method to provide personalized sound therapy while sleeping. A recently released randomized study by the National Center for Rehabilitative Auditory Research led by James Henry, PhD. at the VA Portland Health Care System demonstrated improved clinical outcomes for tinnitus patients using the Levo System.
To learn more about the Levo System visit http://otoharmonics.com.
About Otoharmonics Corporation
Otoharmonics Corporation is a privately held company with headquarters in Portland, Oregon USA. An international team of world–class neuroscientists, clinicians, business professionals and patients, Otoharmonics has developed the patented Levo System for the management of tinnitus symptoms. With a personal approach and a deep understanding of the impact tinnitus can have, Levo is designed to be user-friendly and capable of delivering custom sound therapy based on the specific needs of the individual.
Otoharmonics and Levo are registered trademarks of Otoharmonics Corporation.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/otoharmonics-appoints-director-of-business-development-300451416.html
SOURCE Otoharmonics Corporation